What is the Non-opioid Topical Pain Relief market size?

The Non-opioid Topical Pain Relief market size is approximately USD 1.2 billion as of 2023.

What are the key drivers of the Non-opioid Topical Pain Relief market?

Key drivers include rising awareness of opioid risks and growing demand for effective pain management solutions.

Which regions are leading the Non-opioid Topical Pain Relief market?

North America and Europe are currently the leading regions, driven by high healthcare expenditure.

Who are the top companies in the Non-opioid Topical Pain Relief market?

Top companies include Johnson & Johnson, Pfizer, and GlaxoSmithKline, offering a range of topical pain relief products.

What future opportunities exist in the Non-opioid Topical Pain Relief market?

Future opportunities include emerging markets and innovative product developments, such as nanotechnology-based formulations.

How is technology impacting the Non-opioid Topical Pain Relief market?

Technology is driving innovation, with advances in formulation and delivery systems enhancing product efficacy and patient convenience.

What is the current regulatory landscape for the Non-opioid Topical Pain Relief market?

The regulatory landscape is evolving, with increasing focus on safety and efficacy, and stricter guidelines for product approvals.

What is the future outlook for the Non-opioid Topical Pain Relief market?

The future outlook is positive, with growing demand and increasing investment in research and development driving market growth.

Non-opioid Topical Pain Relief Industry Size, Share & Growth Forecast 2033

Non-opioid Topical Pain Relief by Application (Pharmacy, Clinic, Hospital, Others), by Types (Prescription Pain Relief, Over-The-Counter Pain Relief), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Non-opioid Topical Pain Relief Market Overview

The Non-opioid Topical Pain Relief market refers to the industry segment focused on developing and marketing topical pain relief products that do not contain opioids. As the Non-opioid Topical Pain Relief market size continues to grow, driven by increasing demand for effective and safe pain management solutions, the growth outlook and market forecast indicate a promising future for industry players. The industry expansion is expected to be fueled by rising awareness about the risks associated with opioid-based pain relief products, leading to a shift towards non-opioid alternatives. The current Non-opioid Topical Pain Relief market size is approximately $1.4 billion, with a projected CAGR of 7.5% from 2026 to 2033.

Loading chart…

The Non-opioid Topical Pain Relief market is being shaped by key forces such as technology shifts towards more effective and targeted pain relief solutions, regulations aimed at reducing opioid prescriptions, and changing consumer behavior driven by increasing awareness about health and wellness. The largest region for Non-opioid Topical Pain Relief products is North America, while the fastest-growing region is Asia-Pacific. As the market continues to evolve, industry players must navigate these key forces to capitalize on emerging opportunities and drive growth.

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	14.95 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; GlaxoSmithKline; Pfizer; Hisamitsu; Mylan; Reckitt Benckiser Group; Sanofi; Teva Pharmaceutical; Sun Pharmaceutical Industries; Lingrui Pharmaceutical; Tibet Cheezheng Tibetan Medicine; China Resources Sanjiu Medical & Pharmaceutical; Topical BioMedics; AdvaCare Pharma; Abacus Health Products
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-opioid Topical Pain Relief market is poised for significant growth, driven by increasing demand for effective and safe pain management solutions. The growth forecast for the Non-opioid Topical Pain Relief market size is substantial, with key drivers and restraints shaping the industry landscape.

Growth Drivers2 items

Rising awareness about the risks associated with opioid-based pain relief medications is driving demand for non-opioid alternatives, contributing to the growth of the Non-opioid Topical Pain Relief market size. This shift is fueled by regulatory efforts to curb opioid abuse and promote safer pain management options.

Advances in topical formulation technologies have improved the efficacy and convenience of non-opioid pain relief products, further boosting the growth forecast for the Non-opioid Topical Pain Relief market.

Restraints2 items

High development costs and stringent regulatory requirements for new topical pain relief products can hinder the growth of the Non-opioid Topical Pain Relief market, as companies may be deterred by the significant investment required to bring products to market.

Variability in patient response to non-opioid topical pain relief treatments can affect market growth, as some products may not be effective for all patients, potentially limiting the Non-opioid Topical Pain Relief market size.

Opportunities2 items

The expanding _geriatric_ population and the increasing prevalence of chronic pain conditions present significant opportunities for growth in the Non-opioid Topical Pain Relief market, as this demographic often requires safe and effective pain management solutions.

The trend towards _self-care_ and _over-the-counter_ pain management solutions is creating new avenues for the Non-opioid Topical Pain Relief market, with consumers seeking convenient and accessible products for pain relief.

Challenges2 items

Intense competition in the Non-opioid Topical Pain Relief market, particularly from established pharmaceutical companies and generic manufacturers, can challenge the growth forecast for new market entrants and smaller players.

Ensuring _pricing strategies_ that balance profitability with _affordability_ and _accessibility_ for patients is a significant challenge in the Non-opioid Topical Pain Relief market, requiring careful consideration of regulatory, competitive, and socio-economic factors.

Market Segmentation

Loading chart…

The Non-opioid Topical Pain Relief market can be segmented based on Application, which includes various subtypes such as musculoskeletal pain, neuropathic pain, and inflammatory pain. This segmentation contributes to the overall market size by highlighting the specific areas where non-opioid topical pain relief products are most effective. Understanding the application segment is crucial for Non-opioid Topical Pain Relief segmentation as it helps manufacturers to develop targeted products and marketing strategies.

Another significant segmentation category in the Non-opioid Topical Pain Relief market is Types, which includes subtypes such as topical creams, gels, patches, and sprays. This segmentation is vital as it showcases the various product formats available in the market, each with its unique characteristics, advantages, and user preferences. Analyzing the types segment helps in understanding the market taxonomy and identifying opportunities for innovation and growth.

Non-opioid Topical Pain Relief Segmentation Breakdown8 items

Application

Pharmacy

Clinic

Hospital

Others

Types

Prescription Pain Relief

Over-The-Counter Pain Relief

Regional Insights

Loading chart…

The Non-opioid Topical Pain Relief market growth is expected to vary across regions, driven by factors such as adoption rates, policies, and investments. North America is the largest region, accounting for approximately 35% of the market, driven by high adoption of non-opioid topical pain relief products, favorable policies, and significant investments in research and development.

The fastest-growing region is Asia Pacific, driven by increasing demographics, improving infrastructure, and growing ecosystem maturity. Key drivers for each region include: for North America, adoption of non-opioid topical pain relief products, policies supporting the use of non-opioid pain relief, and investments in research and development; for Europe, demographics with an aging population, infrastructure supporting the use of non-opioid pain relief, and ecosystem maturity with established healthcare systems.

In Latin America and Middle East & Africa, key drivers include adoption of non-opioid topical pain relief products, policies supporting the use of non-opioid pain relief, and investments in healthcare infrastructure. The regional forecast indicates that Asia Pacific will drive the Non-opioid Topical Pain Relief market growth, with a significant increase in demographics and ecosystem maturity.

Competitive Landscape

The Non-opioid Topical Pain Relief market is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Non-opioid Topical Pain Relief competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios and strategic partnerships.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. However, they face challenges such as margin pressure, compliance costs, and commoditization. To differentiate themselves, companies focus on technology, service models, channel strength, customization, and cost advantages. The following companies have notable strategic focuses:

Johnson & Johnson: regional expansion

GlaxoSmithKline: premium pricing

Pfizer: innovation pipeline

Hisamitsu: local manufacturing

Mylan: OEM tie-ups

Reckitt Benckiser Group: vertical integration

Key Non-opioid Topical Pain Relief Companies15 items

Johnson & Johnson

GlaxoSmithKline

Pfizer

Hisamitsu

Mylan

Reckitt Benckiser Group

Sanofi

Teva Pharmaceutical

Sun Pharmaceutical Industries

Lingrui Pharmaceutical

Tibet Cheezheng Tibetan Medicine

China Resources Sanjiu Medical & Pharmaceutical

Topical BioMedics

AdvaCare Pharma

Abacus Health Products

Market Ecosystem

The Non-opioid Topical Pain Relief ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. From technology providers and suppliers to integrators, channels, and end users, each entity contributes to the creation and capture of value within the ecosystem. Understanding the boundaries and interactions between these participants is crucial for conducting a comprehensive value chain analysis.

Raw material/component suppliers — providing active ingredients

OEMs / manufacturers — producing topical pain relief products

Technology providers — developing formulation technologies

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and education

End users / buyers — purchasing and using non-opioid topical pain relief products

Regulators/standards bodies — establishing safety and efficacy standards

Within the Non-opioid Topical Pain Relief ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and standards. Dependency risks arise from input constraints, such as access to active ingredients, and approvals from regulatory bodies. Switching costs and partnerships between participants can also impact the ecosystem, particularly in terms of formulation technologies and distribution channels. Furthermore, the ecosystem may differ by region due to varying regulatory frameworks and market preferences, highlighting the need for a nuanced understanding of these dynamics.

Recent Industry Insights

The Non-opioid Topical Pain Relief industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between pharmaceutical companies and research institutions, have focused on developing innovative topical pain relief products. Mergers and acquisitions have also been on the rise, with companies seeking to expand their product portfolios and strengthen their market presence. Furthermore, several product launches have taken place, introducing new non-opioid formulations and delivery systems to the market.

Additionally, regulatory changes have played a crucial role in shaping the industry, with authorities implementing stricter guidelines for the development and marketing of pain relief products. A notable shift in consumer trends has also been observed, with a growing preference for natural and organic pain relief solutions. Funding rounds and expansions have enabled companies to invest in research and development, driving innovation and growth in the Non-opioid Topical Pain Relief industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Non-opioid Topical Pain Relief market. The market attractiveness is high due to the growing demand for alternatives to opioid-based pain relief solutions. The competitive intensity is moderate, with key players focusing on innovation and expansion of their product portfolios. The long-term outlook for the Non-opioid Topical Pain Relief market outlook is positive, driven by increasing awareness of the risks associated with opioid use and the need for effective pain management solutions.

The innovation landscape is evolving, with companies investing in research and development to create new and improved non-opioid topical pain relief products. The demand-supply balance is stable, with manufacturers working to meet the growing demand for these products. However, key risk factors such as regulatory changes and intense competition may impact the market. Overall, the Non-opioid Topical Pain Relief market is expected to experience steady growth in the coming years.

11 items

1. Executive Summary

2. Non-opioid Topical Pain Relief Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-opioid Topical Pain Relief Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Non-opioid Topical Pain Relief Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmacy

6.1.2. Clinic

6.1.3. Hospital

6.1.4. Others

6.2. Global Non-opioid Topical Pain Relief Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Prescription Pain Relief

6.2.2. Over-The-Counter Pain Relief

6.3. Global Non-opioid Topical Pain Relief Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Non-opioid Topical Pain Relief Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-opioid Topical Pain Relief Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-opioid Topical Pain Relief Market Competition by Key Manufacturers

8.1. Global Non-opioid Topical Pain Relief Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Non-opioid Topical Pain Relief: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Johnson & Johnson

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. GlaxoSmithKline

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Pfizer

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Hisamitsu

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Mylan

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Reckitt Benckiser Group

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Sanofi

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Teva Pharmaceutical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Sun Pharmaceutical Industries

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Lingrui Pharmaceutical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Tibet Cheezheng Tibetan Medicine

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. China Resources Sanjiu Medical & Pharmaceutical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Topical BioMedics

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. AdvaCare Pharma

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Abacus Health Products

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-opioid Topical Pain Relief Market

Figure 4: Global Non-opioid Topical Pain Relief Market: Drivers

Figure 5: Global Non-opioid Topical Pain Relief Market: Challenges

Figure 6: Global Non-opioid Topical Pain Relief Market: Trends

Figure 7: Global Non-opioid Topical Pain Relief Market: Opportunity

Figure 8: Global Non-opioid Topical Pain Relief Market: Restraint

Figure 9: Global Non-opioid Topical Pain Relief Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Non-opioid Topical Pain Relief Market Value (USD Million) By Region

Figure 15: Global Non-opioid Topical Pain Relief Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Non-opioid Topical Pain Relief Market Value (USD Million) By Region

Figure 23: Global Non-opioid Topical Pain Relief Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-opioid Topical Pain Relief Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-opioid Topical Pain Relief Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-opioid Topical Pain Relief Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Non-opioid Topical Pain Relief Market Value (USD Million) By Region

Table 10: Global Non-opioid Topical Pain Relief Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Non-opioid Topical Pain Relief Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Non-opioid Topical Pain Relief Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Non-opioid Topical Pain Relief Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Johnson & Johnson Basic Information And Sales Area

Table 31: Johnson & Johnson. Products Portfolio

Table 32: GlaxoSmithKline Basic Information And Sales Area

Table 33: GlaxoSmithKline. Products Portfolio

Table 34: Pfizer Basic Information And Sales Area

Table 35: Pfizer. Products Portfolio

Table 36: Hisamitsu Basic Information And Sales Area

Table 37: Hisamitsu. Products Portfolio

Table 38: Mylan Basic Information And Sales Area

Table 39: Mylan. Products Portfolio

Table 40: Reckitt Benckiser Group Basic Information And Sales Area

Table 41: Reckitt Benckiser Group. Products Portfolio

Table 42: Sanofi Basic Information And Sales Area

Table 43: Sanofi. Products Portfolio

Table 44: Teva Pharmaceutical Basic Information And Sales Area

Table 45: Teva Pharmaceutical. Products Portfolio

Table 46: Sun Pharmaceutical Industries Basic Information And Sales Area

Table 47: Sun Pharmaceutical Industries. Products Portfolio

Table 48: Lingrui Pharmaceutical Basic Information And Sales Area

Table 49: Lingrui Pharmaceutical. Products Portfolio

Table 50: Tibet Cheezheng Tibetan Medicine Basic Information And Sales Area

Table 51: Tibet Cheezheng Tibetan Medicine. Products Portfolio

Table 52: China Resources Sanjiu Medical & Pharmaceutical Basic Information And Sales Area

Table 53: China Resources Sanjiu Medical & Pharmaceutical. Products Portfolio

Table 54: Topical BioMedics Basic Information And Sales Area

Table 55: Topical BioMedics. Products Portfolio

Table 56: AdvaCare Pharma Basic Information And Sales Area

Table 57: AdvaCare Pharma. Products Portfolio

Table 58: Abacus Health Products Basic Information And Sales Area

Table 59: Abacus Health Products. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Non-opioid Topical Pain Relief Market Value (USD Million) By Region

Table 65: Global Non-opioid Topical Pain Relief Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Non-opioid Topical Pain Relief Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	14.95 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson & Johnson; GlaxoSmithKline; Pfizer; Hisamitsu; Mylan; Reckitt Benckiser Group; Sanofi; Teva Pharmaceutical; Sun Pharmaceutical Industries; Lingrui Pharmaceutical; Tibet Cheezheng Tibetan Medicine; China Resources Sanjiu Medical & Pharmaceutical; Topical BioMedics; AdvaCare Pharma; Abacus Health Products
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Non-opioid Topical Pain Relief Segmentation Breakdown8 items

Application

Pharmacy

Clinic

Hospital

Others

Types

Prescription Pain Relief

Over-The-Counter Pain Relief

Regional Insights

Loading chart…

Competitive Landscape

Johnson & Johnson: regional expansion

GlaxoSmithKline: premium pricing

Pfizer: innovation pipeline

Hisamitsu: local manufacturing

Mylan: OEM tie-ups

Reckitt Benckiser Group: vertical integration

Key Non-opioid Topical Pain Relief Companies15 items

Johnson & Johnson

GlaxoSmithKline

Pfizer

Hisamitsu

Mylan

Reckitt Benckiser Group

Sanofi

Teva Pharmaceutical

Sun Pharmaceutical Industries

Lingrui Pharmaceutical

Tibet Cheezheng Tibetan Medicine

China Resources Sanjiu Medical & Pharmaceutical

Topical BioMedics

AdvaCare Pharma

Abacus Health Products

Market Ecosystem

Raw material/component suppliers — providing active ingredients

OEMs / manufacturers — producing topical pain relief products

Technology providers — developing formulation technologies

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and education

End users / buyers — purchasing and using non-opioid topical pain relief products

Regulators/standards bodies — establishing safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents